岩田 卓

Medicine & Life Sciences

1. Uterine Cervical Neoplasms 100%
2. Cervical Intraepithelial Neoplasia 54%
3. Human papillomavirus 16 27%
4. Trachelectomy 25%
5. Japan 21%
6. Neoplasms 20%
7. Endometrial Neoplasms 16%
8. Squamous Intraepithelial Lesions 16%
9. Cervix Uteri 14%
10. Genotype 14%
11. Papillomavirus Infections 14%
12. Cell Biology 13%
13. Vaccination 12%
14. Human papillomavirus 18 11%
15. Adenocarcinoma in Situ 11%
16. Human Genome 11%
17. Viral Genome 11%
18. Immunotherapy 11%
19. Adenocarcinoma 10%
20. Hysterectomy 10%
21. Tumor-Infiltrating Lymphocytes 10%
22. Testicular Neoplasms 10%
23. Chemoradiotherapy 9%
24. Neoplasm Metastasis 9%
25. Fertility 9%
26. Genome 8%
27. Drug Therapy 8%
28. T-Lymphocytes 8%
29. Papillomavirus Vaccines 8%
30. Microsatellite Instability 8%
31. Genes 7%
32. Atypical Squamous Cells of the Cervix 7%
33. Neuroendocrine Carcinoma 7%
34. Antigens 7%
35. Survival 7%
36. Genetic Variation 6%
37. Squamous Cell Carcinoma 6%
38. Homeobox Genes 6%
39. Cell- and Tissue-Based Therapy 6%
40. Vaccines 6%
41. Carcinogenesis 6%
42. Colposcopy 6%
43. Therapeutics 6%
44. Immunohistochemistry 6%
45. Confidence Intervals 6%
46. Pancreatic Neoplasms 6%
47. Polymerase Chain Reaction 6%
48. Ovarian Neoplasms 6%
49. Lymph Nodes 6%
50. Early Detection of Cancer 5%